Maverick Capital’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-4,187
| Closed | -$504K | – | 378 |
|
|
2024
Q1 | $504K | Buy |
+4,187
| New | +$504K | 0.01% | 216 |
|
|
2021
Q4 | – | Sell |
-10,120
| Closed | -$1.32M | – | 478 |
|
|
2021
Q3 | $1.32M | Sell |
10,120
-15,738
| -61% | -$2.05M | 0.01% | 230 |
|
|
2021
Q2 | $4.59M | Buy |
25,858
+7,329
| +40% | +$1.3M | 0.04% | 99 |
|
|
2021
Q1 | $3.05M | Buy |
18,529
+9,480
| +105% | +$1.56M | 0.03% | 105 |
|
|
2020
Q4 | $1.49M | Buy |
+9,049
| New | +$1.49M | 0.02% | 174 |
|
|
2019
Q2 | – | Sell |
-39,040
| Closed | -$5.58M | – | 316 |
|
|
2019
Q1 | $5.58M | Buy |
39,040
+1,590
| +4% | +$227K | 0.07% | 177 |
|
|
2018
Q4 | $4.64M | Buy |
37,450
+570
| +2% | +$70.7K | 0.07% | 194 |
|
|
2018
Q3 | $6.2M | Sell |
36,880
-5,030
| -12% | -$846K | 0.08% | 147 |
|
|
2018
Q2 | $7.22M | Sell |
41,910
-20,450
| -33% | -$3.52M | 0.08% | 129 |
|
|
2018
Q1 | $9.42M | Buy |
62,360
+18,820
| +43% | +$2.84M | 0.12% | 106 |
|
|
2017
Q4 | $5.86M | Buy |
43,540
+21,760
| +100% | +$2.93M | 0.07% | 140 |
|
|
2017
Q3 | $3.19M | Buy |
21,780
+6,090
| +39% | +$891K | 0.04% | 139 |
|
|
2017
Q2 | $2.44M | Buy |
15,690
+5,510
| +54% | +$857K | 0.03% | 112 |
|
|
2017
Q1 | $1.48M | Sell |
10,180
-2,060
| -17% | -$299K | 0.02% | 99 |
|
|
2016
Q4 | $1.34M | Buy |
12,240
+2,530
| +26% | +$276K | 0.02% | 91 |
|
|
2016
Q3 | $1.18M | Buy |
9,710
+1,500
| +18% | +$182K | 0.01% | 106 |
|
|
2016
Q2 | $1.16M | Sell |
8,210
-860
| -9% | -$122K | 0.02% | 107 |
|
|
2016
Q1 | $1.18M | Buy |
+9,070
| New | +$1.18M | 0.02% | 89 |
|